ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
Hamad bin Khalifa University at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Hamad bin Khalifa University brings 8 presentations from 5 research groups to ASHG 2026 in Montréal. Its program centres on rare disease, population genetics and computational approaches, with applications in clinical genetics and therapeutics. Genomics and Translational Biomedicine brings pharmacogenomics findings from Qatari cohorts, Qatar Center for Artificial Intelligence brings ancestry-aware association methods, and Cancer Biomarker Discovery and Therapeutic Targeting brings lncRNA vulnerabilities in triple-negative breast cancer.
| Organization | ASHG 2026 Attendance |
|---|---|
Hamad bin Khalifa University Doha, Qatar | 3 PIs · 2 Postdocs · 1 Staff Scientist |
Genomics and Translational Biomedicineelmi.hbku.edu.qa/en/organisations/genomics-and-translational-biomedicine/persons Studies pharmacogenomics, whole-genome sequencing and metabolomics in Qatari cohorts. Projects target personalized treatment in Qatari patients.
| Poster Wed Oct 21 2:30 pm Decoding the Genetic Architecture of Adverse Drug Reactions: A Mendelian Randomization Study of 21 Medications Across 99 Phenotypes Genome-wide association studyMendelian randomizationPrecision medicine Poster Thu Oct 22 4:15 pm SDR42E1 ortholog deficiency uncovers conserved sterol-metabolic pathways influencing lifespan in C. elegans Genome editing/CRISPRRNA-seqEndocrine systemCellular metabolism Poster Thu Oct 22 4:15 pm Population-Scale Pharmacogenomics in Qatar Reveals High Burden of Preventable Adverse Drug Reactions Electronic health recordsExome/genome sequencingPharmacogenomicsPopulation genetics |
Cancer Biomarker Discovery and Therapeutic Targetinghbku.edu.qa/en/qbri/research-teams-research-group_dr-nehad-alajez Studies breast cancer using lncRNA transcriptome data, microRNA and lncRNA, and CRISPR-Cas9 functional screens. Identifies diagnostic, prognostic and treatment-response biomarkers, especially in triple-negative breast cancer.
| Talk Sat Oct 24 10:15 am Genome-scale screening identifies lncRNA vulnerabilities in triple-negative breast cancer CancerEpigeneticsNon-coding RNAMolecular therapeutics |
Genomics of Neurodevelopmental Disordershbku.edu.qa/en/qbri/research-teams-dr-jouke-jan-hottenga Studies genomics and multi-omics data across population-based datasets using bioinformatics, statistical modeling and AI. Investigates prioritized variants in cellular models for precision medicine.
| Poster Thu Oct 22 4:15 pm Genomic analyses reveal novel autism spectrum disorder risk genes in a Middle Eastern Qatari cohort AutismCandidate geneConsanguinityGenetic variation |
Qatar Center for Artificial Intelligenceqcai.qcri.org Develops AI methods on whole-genome sequencing, metabolomics, proteomics, imaging and EHR data. Uses data for biomarkers, disease-risk prediction and patient stratification in Middle Eastern populations.
| Session Thu Oct 22 8:15 am Poster Thu Oct 22 4:15 pm Leveraging Runs of Homozygosity to Identify Rare Susceptibility Loci for Cardiometabolic Traits in Middle Eastern individuals Genetic epidemiologyConsanguinityCardiovascular system |
QBRI - Neurological Disorders Research Centerhbku.edu.qa/en/qbri/neurological-disorders-research-center Uses whole-genome sequencing, proteomics, metabolic studies, stem cells and organoids to study neurological disorders. Partners Qatar Biobank on biomarkers and therapies.
| Poster Thu Oct 22 4:15 pm Whole-genome sequencing reveals the rare variant landscape and novel candidate genes in a Qatari autism spectrum disorder cohort AutismCandidate geneExome/genome sequencingGenetic variation |
| 1 more presenter — research group not yet identified | |
Find decision makers at Hamad bin Khalifa University
Tell us what you sell and we’ll find the people at Hamad bin Khalifa University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction